Log in to your Inderes Free account to see all free content on this page.
Cessatech
19.12 DKK
-6.04 %
Less than 1K followers
CESSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-6.04 %
-0.10 %
+19.80 %
+60.40 %
+71.33 %
+69.20 %
+1,034.72 %
+17.86 %
+77.29 %
Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company focuses on specialty products designed for use in clinical settings and advances its programs through a partnership-based development model. Founded in 2020, Cessatech is headquartered in Denmark and led by a team with experience across drug development and commercialization.
Read moreMarket cap
355.18M DKK
Turnover
1.11M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.2.
2026
Annual report '25
30.3.
2026
General meeting '26
28.5.
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Cessatech: Third Quarter Report Q3-2025
Cessatech: CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio